To promote the advancement and development of ion radiotherapy in China and to strengthen the exchange and sharing of clinical and radiophysical research experience, the "International Training Course on China's Carbon‑Ion Therapy System (Third Session)", hosted by Gansu Wuwei Cancer Hospital, is scheduled to be held from September 16 to September 20, 2026, in Wuwei.

The Department of Traditional Chinese Medicine at Gansu Province Wuwei Tumor Hospital is launching its 2026 Sanfu (Dog Days) patch therapy services, adhering to the principle of "treating winter diseases in summer." The treatment is administered by a team of disciples led by Professor Pei Zhengxue. Professional care is provided for conditions affecting the respiratory system and musculoskeletal joints. For appointments, please call 183-9381-0358 or visit the Outpatient TCM Department.

Frequently Asked Questions (FAQs) for Radiotherapy Patients

On May 27, Professor Feng Qinfu, a national chief expert, visited the Heavy Ion Center of Gansu Province Wuwei Tumor Hospital to provide clinical guidance. He went deep into the front lines of clinical practice, conducted ward rounds and discussions on difficult cases, promoted further upgrades in radiotherapy technology, and provided precise diagnostic and treatment guarantees for chest tumor patients in the northwest region.

Gansu Province Wuwei Tumor Hospital has been approved for its first provincial chief scientist project, led by Professor Ye Yancheng to tackle radiation-resistant tumors with carbon ion therapy. Leveraging 30 major research platforms and 9 globally advanced technologies, the hospital is developing a "China Solution" to provide new hope for precise treatment of refractory cancers such as pancreatic cancer and glioblastoma.

Explore the "multimodal integration" cocktail therapy, scientifically combining chemotherapy, targeted therapy, immunotherapy, and anti-angiogenic drugs like mixing cocktails to customize personalized treatment plans for cancer patients. Professor Pan Ming's team at Lanzhou Campus of Gansu Wutai Cancer Hospital leverages MICM precision diagnostics and laminar flow wards to provide refined diagnosis and treatment for lung cancer, hematologic diseases, and more, improving survival rates and quality of life.

The Lanzhou campus of Gansu Provincial Wuwei Tumor Hospital has launched a clinical study on zero out-of-pocket expenses for heavy ion therapy in high-grade gliomas. The Phase II trial combining carbon ion and photon radiotherapy is recruiting 23 patients, covering approximately 156,000 yuan in treatment costs. Aimed at improving survival rates, eligible individuals are welcome to register for consultation.

With the continuous deepening of population aging in China, the incidence rate of benign prostatic hyperplasia (BPH) among middle-aged and elderly men has been rising annually, becoming one of the prevalent chronic diseases that significantly impair the daily quality of life for men.

The Lanzhou campus of Gansu Wuhui Cancer Hospital has launched a clinical study on radical carbon ion radiotherapy for breast cancer, with patients receiving treatment at zero out-of-pocket cost. This project aims to align with international standards by using precise carbon ion radiotherapy to achieve surgery-free and breast-conserving outcomes. Led by top experts including Shen Wenjiang and Wang Junjie, the Phase II clinical trial will recruit 42 eligible breast cancer patients.

Gansu Province Wuwei Cancer Hospital has launched research on using carbon ion therapy to treat benign diseases such as rheumatoid arthritis, offering a new low-dose carbon ion irradiation protocol. Patients will have zero out-of-pocket expenses, fully covered by research funding. Volunteers with refractory rheumatoid arthritis are being recruited to explore new mechanisms of anti-inflammatory and immunomodulatory effects, contributing to medical advancements.